Macquarie Group
CPIX icon

Macquarie Group’s Cumberland Pharmaceuticals CPIX Stock Holding History

Macquarie Group’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,094
Closed -$13K – 1714
2018
Q4 		$13K Sell
2,094
-3,624
-63% -$21.7K ﹤0.01% 1875
2018
Q3 		$33K Buy
5,718
+1,618
+39% +$9.53K ﹤0.01% 1798
2018
Q2 		$25K Buy
+4,100
New +$25.6K ﹤0.01% 2037

Other funds holding CPIX

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Macquarie Group's CPIX Position: Q1 2019 in Review

Macquarie Group sold out of Cumberland Pharmaceuticals (CPIX) in Q1 2019, closing a stake of 2,094 shares — an estimated $13K sold.

Macquarie Group first reported a position in CPIX in Q2 2018 and held it in 3 quarters. The position peaked at $33K in Q3 2018. 23 funds tracked by Wall St. Rank hold CPIX as of Q1 2019.

  • Macquarie Group reported no remaining Cumberland Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Macquarie Group sold 2,094 Cumberland Pharmaceuticals shares in Q1 2019, an estimated $13K.
  • Macquarie Group first reported a position in Cumberland Pharmaceuticals in Q2 2018 and held it in 3 quarters.
  • Macquarie Group's Cumberland Pharmaceuticals position peaked at $33K in Q3 2018.
  • 23 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2019.

Based on Macquarie Group's 13F filing for Q1 2019, filed 15 May 2019.